Test Price
50,000 AED✅ Home Collection Available
Genotyping by Sequencing (96‑Sample Batch) in UAE | 50,000 AED | Accredited by DHA
Executive Summary & Core Metrics
Core Metrics at a Glance
- Diagnostic Sensitivity: 99.9% via ISO‑certified NGS workflow.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM–11 PM).
- Clinical Guidance: Post‑test teleconsultation for result interpretation.
- Insurance: Direct coverage verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
This high‑throughput service employs Next‑Generation Sequencing with 96‑unique dual‑index multiplexing to simultaneously genotype DNA from 96 samples, delivering genome‑wide variant calling for oncology research, pharmacogenomics, and population studies. The method detects single‑nucleotide variants, small insertions/deletions, and copy number variations with >99.9% analytical accuracy.
| Feature | Our Genotyping by Sequencing (96‑Plex) | Closest Alternative (Microarray Chip) |
|---|---|---|
| Methodology | Targeted NGS with UDI multiplexing, 99.9% variant accuracy | Fixed‑probe beadchip hybridization, ~98% call rate |
| Throughput | 96 samples processed simultaneously | Single‑sample chips or low‑plex (12–24) |
| Turnaround Time | 5 weeks with full bioinformatics | 8–12 weeks for equivalent panel size |
| Data Depth | Single‑nucleotide variants, indels, CNVs | Limited to known SNP markers |
| Batch Price (AED) | 50,000 AED (whole batch) | ~8,000 AED per sample × 96 = 768,000 AED |
Physician Insight & Safety Protocols
“Genotyping by sequencing offers powerful probabilistic risk insights, but is not a standalone diagnostic tool. For optimal clinical utility, these results must be interpreted alongside comprehensive clinical, family, and pathological data. I strongly advise discussing all findings with a certified genetic counselor or your personal physician before any medical decisions.”
— Ms. Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Medication Advisory
⚠ Important Medication Caution
Do not discontinue or modify any prescribed medication based solely on genotyping results without consulting your treating physician. Genetic data provide risk estimates, not definitive drug‑response instructions.
Safety Exclusion Criteria & Emergency Indicators
- Not for stand‑alone diagnosis: This test is intended for research and susceptibility screening; it cannot replace clinical diagnostic procedures (e.g., biopsy or imaging).
- Informed consent: Patients unable to understand or provide genetic counseling implications are excluded.
- Chain‑of‑custody: Not valid for legal paternity or forensic use without documented court order.
- ER Red Flag: If a report identifies a pathogenic variant linked to a life‑threatening condition (e.g., BRCA1, APC, TP53), do not panic—contact your oncologist or genetics emergency line immediately at +971 54 548 8731.
- Minors: Testing on children (<18 years) strictly follows Federal Decree‑Law No. 4 of 2016 on Medical Liability; parental consent and genetic counseling are mandatory.
Patient FAQ & Clinical Guidance
1. What is the accuracy of 96‑sample genotyping by sequencing compared to older methods?
Our NGS‑based genotyping achieves 99.9% analytical sensitivity and >99.99% reproducibility through unique dual‑indexing. Unlike microarray chips, this method detects novel variants and rare alleles, providing comprehensive haplotype data. Results are validated against reference standards under ISO 9001:2015 quality management.
2. Can I submit my own DNA, or must I provide a blood sample?
You may submit high‑quality extracted DNA (≥2 µg, A260/280 1.8–2.0) or request our VIP mobile phlebotomy team to collect whole blood from your home. Our temperature‑controlled cold‑chain service ensures sample integrity from collection to the sequencing facility. Please specify your preference at booking.
3. How are my genetic data and privacy protected under UAE law?
All genomic data are stored on encrypted, UAE‑based servers compliant with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. We never share identifiable genetic information without your explicit written consent. De‑identified data may be used for clinical validation only with IRB approval.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Protection
This test is conducted under the regulatory oversight of the Dubai Health Authority (DHA Facility License No. 1143) and adheres to Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All clinical and genetic data are processed in accordance with these laws to ensure maximum patient confidentiality and data security.
Clinical & Logistical Metadata
| Test Name | Genotyping by Sequencing (96‑Sample Batch) |
| Price (AED) | 50,000 AED (per batch of 96 samples) |
| Turnaround Time | 5 weeks from sample receipt |
| Sample Type / Matrix | Whole Blood (Peripheral) or Extracted DNA (≥2 µg, A260/280 1.8–2.0) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Unique Dual‑Index (UDI) Multiplexing, Genome‑wide Variant Detection |
| ICD-10-CM Code | Z13.89 (Encounter for screening for other genetic and chromosomal anomalies) |
| LOINC Code | 77949-2 (Gene mutations found [Identifier] in Blood or Tissue by Sequencing) |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians